Like HVH Precision Analytics

closed 7/15/2020 via PR Newswire

Eversana, acquired HVH Precision Analytics

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent: Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2019 via PE Hub

EMV Capital Ltd, acquired Wanda Health

synopsis: EMV Capital, a London-based early-stage venture investor, has acquired Wanda Inc from NetScientific, a transatlantic healthcare IP commercialisation group. Wanda is a digital health company that offers advanced clinical decision support software powered by machine learning to improve and simplify life for people with serious health risks.
buyer: EMV Capital Ltd
EMV Capital (EMVC) is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities, transportation and healthcare sectors. EMVC’s investments cover a range of technologies, including AI, machine learning, IoT, and more. "
target parent: NetScientific
target: Wanda Health
Wanda is a digital health company. Wanda offers advanced clinical decision support software powered by machine learning and real time patient data analysis to improve and simplify life for people with serious health risks. Wanda empowers clinically guided interventions to prevent rehospitalizations.
price ($mm)
$0.20
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/5/2021 via BNC Analysis

Meddo, acquired Doxper

synopsis: Meddo, a digital outpatient care platform in India, has acquired Doxper, a health record management and patient engagement platform in India. Doxper is an AI powered digital pen and paper solution that allows doctors to digitise their case sheets. Their platform provides easy access to patient info and sends automated reminders to patients.
buyer: Meddo
Meddo is a digital outpatient care platform in India. Meddo is re-defining how primary and secondary healthcare is provided in India through a connected care delivery platform. Their platform allows patients to easily book appointments and consult with doctors online. "
target: Doxper
Doxper is a health record management and patient engagement platform in India. Doxper is an AI powered digital pen and paper solution that allows doctors to digitise their case sheets. Their platform provides easy access to patient info and sends automated reminders to patients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/11/2020 via BNC Analysis

Milliman, Inc., acquired Healthio Inc.

synopsis: Brookfield-based and artificial intelligence startup HealthIO, which develops a platform for wearable, internet-connected devices to monitor a person’s health in between clinic visits, has been acquired by Milliman, a Seattle consulting firm.
buyer: Milliman, Inc.
Milliman is among the world's largest providers of actuarial and related products and services. They provide consulting practices in employee benefits, healthcare, investment, life insurance and financial services, and property and casualty insurance. "
target: Healthio Inc.
healthio combines the forces of IoT, Big Data and AI in healthcare to predict adverse events and progression of chronic conditions. healthio is about the DATA​: establishing a longitudinal data pattern and combining it with historical data enables intelligence for early detection.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/10/2019 via PR Newswire

Waystar, acquired Digitize.AI, Inc.

synopsis: Waystar, a leading provider of revenue cycle technology, has acquired Digitize.AI, an artificial intelligence technology (AI) firm providing the healthcare industry with smarter prior authorizations. Digitize.AI offers AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
buyer: Waystar
Waystar provides next-generation, cloud-based technology that simplifies and unifies the healthcare revenue cycle. The Waystar platform removes friction in payment processes, streamlines workflows and improves financials for providers in every care setting. "
target: Digitize.AI, Inc.
Digitize.AI is an artificial intelligence (AI) technology firm providing the healthcare industry with faster and smarter prior authorizations. Digitize.AI offers Lia and Mia, AI enabled systems that help providers and health plans to maximize productivity and improve the member-patient experience.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/29/2020 via Company Press Release

CIOX Health, acquired Medal, Inc.

synopsis: Ciox Health, a leading health technology company, today announced its acquisition of San Francisco-based biomedical Natural Language Processing (biomed-NLP) technology company, Medal, Inc., a leader in the application of AI techniques to the interrogation of unstructured medical record data.
buyer parent: New Mountain Capital, LLC
buyer: CIOX Health
Ciox Health facilitates and manages the movement of health information with the industry’s broadest provider network. They improve the management and exchange of health information by modernizing workflows, facilitating access to clinical data, & improving the accuracy & flow of health information. "
target: Medal, Inc.
Medal, Inc. a leader in the application of AI techniques to the interrogation of unstructured medical record data. Medal’s software helps identify, contextualize, and interpret narrative-based medical notes, leading to the creation of research-grade data sets at scale.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2019 via BNC Analysis

Abeo, Inc., acquired Trusted i10

synopsis: abeo, a leader in physician-focused billing and practice management solutions, has acquired Trusted i10. Trusted i10 has proven next generation technology that solves the issue of medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
buyer parent: Parthenon Capital Partners
buyer: Abeo, Inc.
abeo Management Corporation (abeo) serves as a leading source of revenue cycle management and practice management for hospital-based specialties, originating from deep-rooted experience within Anesthesiology. "
target: Trusted i10
Trusted i10 has proven next generation technology that solves the issue created by modern electronic medical systems: medical record data overload. Through technology, they process copious amounts of free text data and turn it into actionable information.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 2/19/2021 via PR Newswire

MindMed, will acquire HealthMode

synopsis: MindMed, a leading psychedelic medicine biotech company, will acquire HealthMode, a digital medicine and therapeutics startup that uses Artificial Intelligence (AI)-enabled digital measurement to increase the precision and speed of clinical research and patient monitoring.
buyer: MindMed (OTCPK:MMED.F:$0.00)
MindMed is a psychedelic medicine biotech company that discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances. "
target: HealthMode
HealthMode drives progression to next-generation clinical trials by developing and delivering AI-enabled digital measurement methods for clinical trials. Its measurement techniques streamline and provide assurance for screening and eligibility, provide early detection of adverse events, and more.
price ($mm)
$33
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/6/2021 via GlobeNewswire

Life Clips, Inc., acquired Cognitive Apps

synopsis: Life Clips, Inc. has acquired Cognitive Apps Software Solutions Inc., a Canadian developer of AI-powered applications for the healthcare industry and psychedelic research. Life Clips will further develop Cognitive Apps' technology for use in the development and testing of psychedelics for the treatment of various mental health disorders.
buyer: Life Clips, Inc. (OTCPK:LCLP:$0.00)
Life Clips is a software development company. Through the company's subsidiary, Mobeego, it develops and distributes an affordable adapter and single-use, cordless battery that provides an instant shot of power to cellular phones, so users can stay mobile whenever and wherever. "
target: Cognitive Apps
Cognitive Apps is a Canadian developer of AI-powered applications for the healthcare industry and psychedelic research. Its mental health analytics platform empowers companies to measure, understand, and improve the mental well-being of their employees, patients, or customers with easy-to-use tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/25/2021 via Company Press Release

doctari, acquired Planerio

synopsis: doctari, an online specialist healthcare staffing platform in the DACH region, has acquired Planerio, a German intelligent shift scheduling software solution for healthcare providers. Planerio automatically creates optimal schedules based on jobs and employee requests. Their software also features tools for digital time recording, payroll and more.
buyer: doctari
doctari is an online specialist healthcare staffing platform in the DACH region. doctari helps healthcare institutions to find quality doctors and nurses, enabling them to focus more on their business. They offer over 25,000 qualified medical professionals for short and long term positions. "
target: Planerio
Planerio is a German intelligent shift scheduling software solution for healthcare providers. Planerio automatically creates optimal schedules based on jobs, employee requests, and vacations. Their software also features tools for digital time recording, payroll, absence management, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/4/2019 via PR Newswire

Waystar, acquired Recondo Technology

synopsis: Waystar, a leading provider of revenue cycle technology, announced the acquisition of Recondo Technology, a pioneer of innovative revenue cycle automation solutions powered by advanced robotic process automation (RPA) and other artificial intelligence technology allowing providers to be paid more, faster and at lower cost.
buyer parent: Bain Capital
buyer: Waystar
Waystar provides cloud-based technology that simplifies and unifies the healthcare revenue cycle. Their platform removes friction in payment processes, streamlines workflows and improves financials for providers. They support over 450,000 providers, 750 health systems, and 5,000 health plans. "
target: Recondo Technology
Recondo Technology's AI-powered software-as-a-service (SaaS) platform helps healthcare providers achieve sustainable financial performance. Recondo delivers industry-leading automated, accurate, and actionable financial clarity to the healthcare revenue cycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/25/2019 via BNC Analysis

Netmeds Marketplace Limited, acquired KiViHealth

synopsis: Online pharmacy NetMeds Marketplace Pvt. Ltd has acquired health-tech startup KiViHealth. KiViHealth is a clinic management platform that allows doctors to generate digital prescriptions. It also offers electronic historical health records storage. The KiViHealth app also provides an appointment booking module and a patient engagement tool.
buyer: Netmeds Marketplace Limited
NetMeds lets users order their medicines via its portal and mobile app by uploading their prescriptions. A team of qualified pharmacists verifies the prescription for validity and prescribes the appropriate dosage accordingly. NetMeds is based in Chennai, India. "
target: KiViHealth
KiViHealth is a clinic management platform that allows doctors to generate digital prescriptions. It also offers electronic historical health records storage. The KiViHealth app also provides an appointment booking module and a patient engagement tool, along with billing invoicing solutions.
price ($mm)
$10
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/11/2021 via Yahoo, Inc.

RxE2, will acquire Habitu Health

synopsis: RxE2, which is bringing the practice of pharmacy to clinical research, has agreed to acquire Habitu, an Israeli-based technology company. Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes.
buyer: RxE2
RxE2 is the first company to make decentralized clinical trials a cost-effective reality. By integrating the practice of pharmacy into every aspect of clinical trials, RxE2 empowers local pharmacists to make clinical trials more accessible to patients, everywhere. "
target: Habitu Health
Habitu focuses on people's habits and behaviors to create a KyP (know your patient) engine enabled by artificial intelligence, improving patient outcomes by providing real-time analyses of a more comprehensive set of patient data.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2019 via BusinessWire

Thrive Global, acquired Boundless Mind

synopsis: Thrive Global, the leading behavior change technology company, announced the acquisition of Boundless Mind, the neuroscience-based artificial intelligence company and leader in behavioral design and engineering.
buyer: Thrive Global
Thrive Global is a behavior change technology company helping individuals, companies and communities improve their well-being and performance. They offer science-based solutions to enhance both mental and physical well-being and performance, purpose and relationship with technology. "
target: Boundless Mind
Boundless Mind is the neuroscience-based artificial intelligence company and leader in behavioral design and engineering. Boundless Mind’s innovative technology fuses neuroscience and AI to optimize, personalize and target recommendations to users to inspire positive behavior change.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/6/2019 via BNC Analysis

PerfectServe, Inc., acquired Lightning Bolt Solutions Inc.

synopsis: PerfectServe, a Tennessee-based medical communication and collaboration platform, announced the acquisition of Lightning Bolt Solutions, an artificial intelligence-run physician shift scheduling technology designed for hospital and healthcare system.
buyer parent: K1 Investment Management
buyer: PerfectServe, Inc.
PerfectServe® is healthcare’s most comprehensive and secure care team collaboration platform. The platform is unique in its ability to improve communication process accuracy and reliability via its proprietary Dynamic Intelligent Routing® capability. "
target: Lightning Bolt Solutions Inc.
Lightning Bolt Solutions is an artificial intelligence-run physician shift scheduling technology designed for hospital and healthcare system. Lightning Bolt Solutions is able to consider recurring department meetings, physician preferences, on-call management, holiday distributions, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/13/2021 via BNC Analysis

Edifecs, acquired Talix

synopsis: Bellevue, Wash.-based health software company Edifecs has acquired Talix, a San-Francisco based startup that mines language in health data to optimize billing, analysis and management of patient data with a focus on value-based care. Talix uses natural language processing, a computational approach to examine language in data.
buyer: Edifecs
Edifecs develops innovative, cost-cutting solutions to transform the global healthcare marketplace. Since 1996, Edifecs technology has helped healthcare providers, insurers, pharmacy benefit management companies, and other trading partners trim waste, reduce costs and increase revenues. "
target: Talix
Talix provides risk and quality solutions to help providers, payers, and accountable care organizations address the growing challenges of value-based care. Talix offers a comprehensive, AI-powered SaaS platform to make the transformation to value-based reimbursement more seamless and effective.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/28/2017 via PR Web

TruClinic, acquired Overl.ai, Inc.

synopsis: TruClinic Inc. announced that it has acquired privately held Overl.ai Inc., a healthcare automation intelligence company based in New York. Overl.ai provides an award-winning self-service patient intake solution that combines machine learning and automation to improve data capture and patient experience.
buyer: TruClinic
TruClinic provides web-based telemedicine solutions for providers and organizations in the healthcare industry. The company offers a secure, high definition video communication system, as well as a suite of practice management products that extend the reach of healthcare practices. "
target: Overl.ai, Inc.
Overl.ai provides an award-winning self-service patient intake solution that combines machine learning and automation to improve data capture. It can capture clinical and non-clinical information, process insurance eligibility, collect payments, schedule appointments, and collect surveys.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/18/2011 via GlobeNewswire

M*Modal merged with MedQuist Inc.,

synopsis: MedQuist Holdings Inc., a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced that it has closed on the acquisition of M*Modal, a leader in advanced Speech and Natural Language Understanding technology.
buyer: MedQuist Inc.
MedQuist is a leading provider of medical transcription services and a leader in technology-enabled clinical documentation workflow. Its enterprise solutions include mobile voice capture devices, speech recognition, Web-based workflow platforms and a global network of medical editors. "
target: M*Modal
M*Modal, a leader in advanced Speech and Natural Language Understanding technology, transforms narrative medical documentation into structured, encoded information to create meaningful, valuable clinical intelligence that can be shared, analyzed, and used to inform collaborative care.
price ($mm)[EV]
$104 [$96]
rev ($mm)
$20
EBITDA ($mm)
$7
EV / rev
6.2x
EV / EBITDA
18.3x
closed 6/9/2021 via BusinessWire

Elligo Health Research, acquired Root Health, Inc.

synopsis: Elligo Health Research, a healthcare-enabling research organization, has acquired Root Health, an AI virtual assistant for clinical research. Root Health helps researchers to compile, track, and support study operations through a dashboard. It automates participant communication, triage, and reporting so users can focus on clinical interactions.
buyer: Elligo Health Research
Elligo Health Research, a healthcare-enabling research organization, uses electronic health records and the trusted patient and physician relationship to ensure all patients have access to clinical research as a care option. "
target: Root Health, Inc.
Root Health is an AI virtual assistant for clinical research. Root Health helps researchers to compile, track, and support study operations through a dashboard. It automates participant communication, triage, data collection, and reporting so users can focus on one-on-one clinical interactions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/6/2020 via BNC Analysis

Graph Blockchain Inc., will acquire Third Eye Insights Corp.

synopsis: Graph Blockchain Inc., a Canadian blockchain solutions company, will acquire Third Eye Insights Corp., a Canadian provider of cloud-based analytics solutions for the alternative medicines industry. Third Eye Insights' platform uses AI to analyze critical social media data. They enable organizations to better understand their target audience.
buyer: Graph Blockchain Inc. (CNSX:GBLC:$0.34)
Graph Blockchain is a Canadian blockchain solutions company. Their enterprise platforms provide solutions for data management, business intelligence and data analytics, by delivering unparalleled processing speed and uncompromising performance quality for corporations and government agencies. "
target: Third Eye Insights Corp.
Third Eye Insights is a Canadian provider of cloud-based analytics solutions for the alternative medicines industry. Third Eye Insights' platform uses AI to cleanse and analyze critical social media data. They enable organizations to better understand their target audience and make better decisions.
price ($mm)
$1.79
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/15/2020 via PR Newswire

Eversana, acquired HVH Precision Analytics

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent: Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/9/2020 via BNC Analysis

Eversana, acquired Alkemy Partners LLC

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of Alkemy Partners, a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Alkemy Partners LLC
Alkemy Partners is a full-service field learning and development company committed to solving market access, sales and clinical engagement through training, content creation and digital solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/15/2020 via PR Newswire

Eversana, acquired HVH Precision Analytics

synopsis: EVERSANA™, the leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform. Previously owned by Havas Health & You and Perspecta, HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target parent: Vivendi SA
target: HVH Precision Analytics
HVH Precision Analytics and its predictive analytics platform leverage analytic expertise originally honed to support military and U.S. intelligence community. HVH's Artificial Intelligence (AI) and machine learning platform has been refined to transform the healthcare sector.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/30/2019 via Company Press Release

Eversana, will acquire Cornerstone Research Group

synopsis: EVERSANA™, the leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group, Inc. Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies.
buyer parent: Water Street Healthcare Partners
buyer: Eversana
EVERSANA offers a fully integrated and independent commercial services platform designed to solve global pricing, access, reimbursement, adherence and product delivery challenges in the life science sector. "
target: Cornerstone Research Group
Cornerstone is a global health economic and market access research company supporting pharmaceutical and medical device companies. Founded in 2005, Cornerstone’s initial focus was to build on the partners’ experience in health economic research with an emphasis on global cost-effectiveness models.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/9/2020 via BusinessWire

The Clarke Companies, acquired Covex, LLC

synopsis: The Clarke Companies, a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry, has acquired Covex, LLC, the premier global provider of validation, compliance, engineering and IT services for the Pharmaceutical, Life Sciences, and Chemical industries.
buyer: The Clarke Companies
The Clarke Companies is a leading provider of packaging, automation, validation and vision inspection services to the Life Sciences Industry. The Clarke Companies include Clarke Solutions and Acquire Automation. "
target: Covex, LLC
Covex, LLC is the premier global provider of validation and compliance services for the Pharmaceutical, Life Sciences, and Chemical industries. Covex Systems Validation, Regulatory Compliance, Engineering and IT Services offer an end-to-end solution for their clients.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/27/2018 via Company Press Release

The WIRB-Copernicus Group, acquired ACI Clinical

synopsis: WIRB-Copernicus Group, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, has acquired ACI Clinical, a specialty provider of clinical trial committees and clinical trial advisory services.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world's leading provider of solutions to measurably improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: ACI Clinical
ACI Clinical is a specialty provider of clinical trial committees and clinical trial advisory services. ACI Clinical specializes in clinical and safety consulting, including full service Endpoint Adjudication Committees and Data Monitoring Committees.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/15/2014 via BNC Analysis

Synchrogenix Information Strategies, Inc. merged with Certara,

synopsis: Arsenal Capital Partners have acquired Synchrogenix Information Strategies Inc., which will merge with Certara LP. Synchrogenix, a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide.
buyer parent: Arsenal Capital Partners
buyer: Certara (:$261.77)
Certara™ is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical development, with special focus on supporting translational approaches to drug development. "
target: Synchrogenix Information Strategies, Inc.
Synchrogenix is a specialty contract research organization providing strategic regulatory writing and related services to pharmaceutical, biotechnology, and medical device companies worldwide. The company offers pre-clinical, clinical, CMC, and drug safety writing and submission services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/4/2013 via PR Newswire

Accelera Innovations, Inc., will acquire Behavioral Health Care Associates, Ltd.

synopsis: Accelera Innovations, Inc., a provider of cloud based software-as-a-service solutions to the healthcare industry announced that they have signed a stock purchase agreement to acquire 100% of Behavioral Health Care Associates, Ltd., a provider of billing, practice management and administrative services to doctors and other clinicians.
buyer: Accelera Innovations, Inc.
Accelera Innovations, Inc. offers cloud based software-as-a-service solutions to the healthcare industry that includes technology and services to providers and payers, who are seeking to create an interoperable technology platform that is patient-centric. "
target: Behavioral Health Care Associates, Ltd.
Behavioral Health Care Associates, Ltd. provides billing, practice management and administrative services to doctors and other clinicians who provide services to hospitals, nursing homes and individual clients.
price ($mm)
$4.55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/21/2013 via BNC Analysis

DrugDev, acquired CFS Clinical

synopsis: DrugDev, an interactive network and data sharing platform for over 80,000 clinical trial doctors in 93 countries, announced its acquisition of CFS Clinical (CFS), the leading specialty provider focused on the business and financial management activities for clinical trials.
buyer: DrugDev
DrugDev helps the clinical trials industry run faster, cheaper and smarter trials. Experienced Investigators choose to be part of the free network to access new clinical trial opportunities they would not otherwise have learnt about. "
target: CFS Clinical
CFS Clinical (CFS) is a technology-enabled service provider focused on the business and financial management activities for clinical trials.CFS’ experts deliver best-in-class Investigator site payment and study startup solutions around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/20/2012 via PR Newswire

ePharmaSolutions, Inc., acquired Polaris Biopharma Consulting

synopsis: ePharmaSolutions announced the acquisition of Polaris BioPharma Consulting, a leading global patient recruitment and retention firm headquartered in Slough, UK. Polaris Biopharma was founded in 1999 as a boutique patient recruitment and retention firm supporting global pharmaceutical companies.
buyer: ePharmaSolutions, Inc.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology. "
target: Polaris Biopharma Consulting
Polaris Biopharma Consulting is a boutique patient recruitment and retention firm. Polaris has helped large and mid-sized pharmaceutical companies and CROs develop and deploy hundreds of global feasibility, trial optimisation and patient recruitment programs in every major therapeutic area.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2006 via BusinessWire

Applied Clinical Intelligence merged with TAKE Solutions, Inc.,

synopsis: TAKE Solutions, Inc. announced the formation of the OneClinical brand of life sciences offerings as part of its merger with Applied Clinical Intelligence and OnSphere Corporation. OneClinical combines a full spectrum of proven data and document management software products and services for clinical trials, drug and device development lifecycles.
buyer parent: Shriram Group
buyer: TAKE Solutions, Inc. (BSE:532890:$259.76)
TAKE Solutions is a leading international business technology company with products backed by a strong domain expertise to provide cost-effective comprehensive solutions for businesses. "
target: Applied Clinical Intelligence
Applied Clinical Intelligence was founded in 2001 to provide data-driven solutions for clinical trials and risk management programs. ACI is a specialized clinical services group offering strategic, operational, and technical intelligence.
price ($mm)
$4.71
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via Company Press Release

Thomson Pharma, acquired Pharmaceutical Information Associates, Ltd.

synopsis: The Thomson Corporation announced that it has acquired Pharmaceutical Information Associates Ltd (PIA) and Astrolabe Analytica, Inc. (AAI). PIA and AAI are leading providers of regulatory consulting, marketing analytics and scientific communications services for the pharmaceutical industry.
buyer parent: The Thomson Corporation
buyer: Thomson Pharma
Thomson Pharma is a dynamic, information offering for the pharmaceutical and biotechnology industries that is being developed by Thomson Scientific. "
target: Pharmaceutical Information Associates, Ltd.
Since 1990, Pharmaceutical Information Associates has supported the global drug development process by assisting with regulatory strategy development, the preparation of regulatory documentation, and the design, conduct, and audit of specialized clinical studies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/2/2020 via Company Press Release

Cytel Inc., acquired Laiya Consulting, Inc.

synopsis: Cytel Inc. has announced the acquisition of Laiya Consulting, a drug development solutions company specializing in Bayesian adaptive trial designs and implementation. Laiya pioneered the delivery of trial design software using SaaS, which aligns with Cytel’s goal of making all of its design software available as a cloud-based service.
buyer parent: New Mountain Capital, LLC
buyer: Cytel Inc.
Cytel provides statistical software for clinical trials. Cytel provides an understanding of software tools that solve statistical problems and that meet the highest standards of reliability, technical documentation and customer support. "
target: Laiya Consulting, Inc.
Founded in 2010, Laiya Consulting has supported drug developers to drive success rates and maximize portfolio returns through the design and implementation of Bayesian adaptive trials, robust clinical strategies, and integrated software platforms.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via Company Press Release

Advarra, acquired Kinetiq

synopsis: Advarra, the premier provider of institutional review board (IRB) and research quality and compliance consulting services, acquired Quorum’s research and technology consulting division, Kinetiq. Kinetiq delivers innovative solutions for human subject protection and compliance in clinical research.
buyer parent: Linden Capital Partners
buyer: Advarra
Advarra, headquartered in Columbia, Md., provides institutional review board (IRB), institutional biosafety committee (IBC) and global research compliance services to clinical trial sponsors, CROs, hospital systems, academic medical centers and investigators. "
target parent: Quorum Review IRB
target: Kinetiq
Kinetiq is a consulting and technology division of Quorum Review IRB that delivers innovative solutions for human subject protection and compliance in clinical research.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/23/2019 via Company Press Release

21 Partners, acquired ProductLife Group

synopsis: 21 Invest France has acquired ProductLife Group.ProductLife Group is an expert in regulatory affairs outsourced management and pharmacovigilance for the Healthcare and Life Sciences industries and more specifically for pharmaceutical laboratories.
buyer: 21 Partners
European-based 21 Partners uses reasonable efforts to obtain information from sources which it believes to be reliable, no representation or warranty is given that the information or opinions contained in this website are accurate, reliable or complete. "
target: ProductLife Group
Based in France, ProductLife Group is the global leader in regulatory and safety services, consulting, and outsourcing solutions for the life sciences industry. ProductLife Group is built on a unique and functional platform-and-geographic-hub model.
price ($mm)
rev ($mm)
$28
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2018 via PR Newswire

Premier Research Group, acquired Regulatory Professionals, Inc.

synopsis: Premier Research, a global provider of clinical development services to biopharmaceutical product innovators, has acquired Regulatory Professionals, Inc. (RPI), a California-based company that provides regulatory expertise and solutions to biotechnology, pharmaceutical, and medical device companies.
buyer parent: ECI Partners
buyer: Premier Research Group
Premier Research is a leading clinical development service provider that helps biotech and specialty pharma innovators — small companies with big ambitions — transform life-changing ideas into new medicines. "
target: Regulatory Professionals, Inc.
Regulatory Professionals, Inc. (RPI) provides strategic advice, regulatory planning, and a full range of submission services, helping its clients advance the development and registration of their products in worldwide markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via Company Press Release

Linden Capital Partners, acquired ProPharma Group

synopsis: Linden Capital Partners, a Chicago-based healthcare private equity firm, announced that it has completed its acquisition of ProPharma Group. ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
buyer: Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. "
target: ProPharma Group
ProPharma Group is a leading provider of outsourced medical information, pharmacovigilance, and compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/26/2012 via BusinessWire

Accenture, acquired Octagon Research Solutions, Inc.

synopsis: Accenture completed its acquisition of Octagon Research Solutions, a provider of clinical and regulatory information management solutions and software for the pharmaceutical industry. The acquisition enhances Accenture's existing clinical services capabilities – including clinical data management, clinical programming and safety case processing.
buyer: Accenture (ACN:$50,533.39)
Accenture is a global management consulting, technology services and outsourcing company. Accenture collaborates with clients to help them become high performance businesses and governments. "
target parent: Edison Ventures
target: Octagon Research Solutions, Inc.
Octagon Research Solutions is the world leader in clinical and regulatory information management solutions to the life sciences industry. Through an integrated suite of outsourced services, strategic consulting, and innovative technology, Octagon optimizes the entire drug development lifecycle.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/18/2012 via BusinessWire

Adjility Health will be merged with Alliance Life Sciences Consulting Group, Inc,

synopsis: Alliance Life Sciences Consulting Group (ALSCG), a leading management and technology consultancy, and Adjility Consulting, a consulting firm specializing in management consulting and analytic solutions for clinical operations and the global market access, pricing and reimbursement space, announced that the two companies will merge.
buyer: Alliance Life Sciences Consulting Group, Inc
Alliance Life Sciences Consulting Group employs more than 175 professionals who collectively understand the business challenges of the Life Sciences industry and offer solutions for Sales & Marketing, Managed Care & Government Contracting, Commercial Operations, Information Management and Analytics."
target: Adjility Health
Adjility Health is dedicated to helping healthcare companies improve their operations through the use of strategic consulting services and very industry domain-specific analytic, forecasting, predictive trending and other data insight tools.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/3/2012 via BusinessWire

Dohmen Company, acquired BioSoteria, Inc.

synopsis: The Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry. The BioSoteria management team has experience building drug safety departments from the ground up at start-up companies and expanding pharmacovigilance capabilities for larger companies.
buyer: Dohmen Company
Dohmen is a provider of outsourced business services. Dohmen’s portfolio of service offerings includes outsourced business services to life science manufacturers through DDN, and benefit management services to life science payers through RESTAT. "
target: BioSoteria, Inc.
BioSoteria provides a broad range of drug safety services to the biopharmaceutical industry. BioSoteria helps companies manage the safety of their products with a regulatory-compliant, best-practices approach. Being a trusted pharmacovigilance service provider begins with leadership.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/13/2016 via BusinessWire

Vitruvian Partners LLP, acquired Phlexglobal

synopsis: Phlexglobal, the thought leaders and specialists in the provision of electronic Trial Master File systems and services to the life sciences industry, announced an investment by Vitruvian Partners. The transaction establishes Vitruvian as majority shareholder of Phlexglobal, while previous majority investor Bridgepoint will exit the company.
buyer: Vitruvian Partners LLP
Vitruvian Partners is an independent European private equity firm that invests in high-growth Dynamic Situations. They focus on asset-light companies in targeted sectors with strong, sustainable growth, and in companies driven by new competitive advantage, a transition in business model, or events. "
target parent: Bridgepoint
target: Phlexglobal
Phlexglobal is a specialist provider of technology-enabled, Trial Master File (TMF & eTMF) document management solutions and other support services to the global clinical research market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like HVH Precision Analytics


read more

HVH Precision Analytics

Wanda Health

Doxper

Healthio Inc.

Digitize.AI, Inc.

Medal, Inc.

Trusted i10

HealthMode

Cognitive Apps

Planerio

Recondo Technology

KiViHealth

Habitu Health

Boundless Mind

Lightning Bolt Solutions Inc.

Talix

Overl.ai, Inc.

M*Modal

Root Health, Inc.

Third Eye Insights Corp.

read more

HVH Precision Analytics

read more

Alkemy Partners LLC

HVH Precision Analytics

Cornerstone Research Group

read more

Covex, LLC

ACI Clinical

Synchrogenix Information Strategies, Inc.

Behavioral Health Care Associates, Ltd.

CFS Clinical

Polaris Biopharma Consulting

Applied Clinical Intelligence

Pharmaceutical Information Associates, Ltd.

Laiya Consulting, Inc.

Kinetiq

ProductLife Group

Validant

Regulatory Professionals, Inc.

Registrar Corp

ProPharma Group

Octagon Research Solutions, Inc.

Adjility Health

BioSoteria, Inc.

Tri Stat

Phlexglobal

Geography
Matching Companies
Ticker: CNSX:PHGI
 
 
 
 
 
 
 
 
Premier Health Group Inc.
Premier Health is strategically poised to take advantage of business opportunities in the global health care industry. Their subsidiary, HealthVue, is focused on developing proprietary technology to deliver quality healthcare through the combination of telemedicine and artificial intelligence (AI).
year
2020
rev ($mm)
$9.28
EBITDA ($mm)
($6.35)
EBIT ($mm)
($6.38)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSXV:CRBK
 
 
 
 
 
 
 
 
Carebook Technologies Inc.
Carebook Technologies Inc.
Built on a powerful health platform, Carebook creates highly engaging, customer-centric digital products for pharmacies, insurance providers, governments, businesses, and more. Carebook’s core is science and technology, and its goal is accessible, connected health for everyone.
year
2020
rev ($mm)
$2.87
EBITDA ($mm)
($4.24)
EBIT ($mm)
($4.44)
Net Income ($mm)
Employees
38
  • drill down
  • watch
Ticker: TSXV:MSD
 
 
 
 
 
 
 
 
Moseda Technologies, Inc.
Moseda Technologies, Inc.
Moseda Technologies is a software developer of secure mobile health and telemedicine solutions for the healthcare sector. Their SmartCare solution integrates the latest in mobile, wearables and SaaS technology to provide increased levels of efficiency and reduction in redundant administrative tasks.
year
2015
rev ($mm)
$0.02
EBITDA ($mm)
($1.86)
EBIT ($mm)
($1.86)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: AIM:CRON
 
 
 
 
 
 
 
 
Cronin Group PLC
Cronin Group PLC provides medical research and development services. The Company focuses on the discovery, development, and manufacture of small molecules and nano-materials utilizing proprietary chemistry. Cronin Group offers its services in the United Kingdom.
year
2018
rev ($mm)
EBITDA ($mm)
($2.29)
EBIT ($mm)
($2.34)
Net Income ($mm)
Employees
25
  • drill down
  • watch
Ticker: TSXV:DNAX
 
 
 
 
 
 
 
 
BLOCKStrain
BLOCKStrain
BLOCKStrain Technology Corp. has developed the first integrated blockchain platform that registers and tracks intellectual property for the cannabis industry. They are based in Vancouver, BC, Canada.
year
2018
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: WX
 
 
 
 
 
 
 
 
WuXi AppTec
WuXi AppTec
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States. WuXi AppTec provides a broad and integrated portfolio of services throughout the drug R&D process.
year
2014
rev ($mm)
$640.80
EBITDA ($mm)
$155.57
EBIT ($mm)
$108.53
Net Income ($mm)
$112.01
Employees
7445
  • drill down
  • watch
Ticker: AIM:C4XD
 
 
 
 
 
 
 
 
C4X Discovery
C4X Discovery aims to become the world’s most productive drug discovery and development company by exploiting cutting-edge technologies to design and create best-in-class drug candidates.
year
2015
rev ($mm)
$0.44
EBITDA ($mm)
($5.46)
EBIT ($mm)
($5.50)
Net Income ($mm)
Employees
19
  • drill down
  • watch
Ticker: BSE:532890
 
 
 
 
 
 
 
 
TAKE Solutions, Inc.
TAKE Solutions, Inc.
TAKE Solutions delivers domain-intensive services in Life Sciences and Supply Chain Management. Their range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.
year
2018
rev ($mm)
$259.76
EBITDA ($mm)
$39.17
EBIT ($mm)
$33.43
Net Income ($mm)
$28.24
Employees
1500
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: XTRA:EVT
 
 
 
 
 
 
 
 
Evotec BioSystems GmbH
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.
year
2017
rev ($mm)
$226.46
EBITDA ($mm)
$53.38
EBIT ($mm)
$38.55
Net Income ($mm)
$40.69
Employees
1316
  • drill down
  • watch
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2021
rev ($mm)
$4,730.38
EBITDA ($mm)
$633.74
EBIT ($mm)
$407.86
Net Income ($mm)
$235.93
Employees
24310
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: EMED
 
 
 
 
 
 
 
 
MedCom USA, Inc.
MedCom USA, Inc. (EMED) provides innovative healthcare and financial transaction solutions for electronically processing HIPAA compliant transactions within the healthcare industry.
year
2008
rev ($mm)
$2.90
EBITDA ($mm)
($0.40)
EBIT ($mm)
($0.62)
Net Income ($mm)
Employees
13
  • drill down
  • watch
Ticker: MCK
 
 
 
 
 
 
 
 
McKesson Corporation
McKesson Corporation
McKesson Corporation is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care.
year
2019
rev ($mm)
$214,319.00
EBITDA ($mm)
$4,229.00
EBIT ($mm)
$3,280.00
Net Income ($mm)
$34.00
Employees
70000
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: EXAM
 
 
 
 
 
 
 
 
ExamWorks, Inc.
ExamWorks, Inc.
ExamWorks, Inc. is a leading provider of independent medical examinations, peer reviews, bill reviews, Medicare compliance service and IME-related services to the insurance and legal industries, third-party administrators, self-insured parties and federal and state agencies.
year
2015
rev ($mm)
$819.57
EBITDA ($mm)
$115.67
EBIT ($mm)
$59.98
Net Income ($mm)
$5.59
Employees
3150
  • drill down
  • watch